N.J. High Court Mulls Vioxx Class Status; $30B At Stake

By Catherine Fredenburgh · July 24, 2006, 12:00 AM EDT

In a decision that dramatically raises the stakes for Merck & Co., New Jersey's State Supreme Court has agreed to hear the drug maker's appeal of the class certification of a...

To view the full article, register now.